This inventor holds 1 USPTO granted patent. Top assignee: Stemergie Biotechnology Sa. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Joana Matos: Innovator in Mitochondrial Research
Introduction
Joana Matos is a prominent inventor based in Zurich, Switzerland. She has made significant contributions to the field of biotechnology, particularly in the area of cancer treatment. Her innovative work focuses on the development of inhibitors that target mitochondrial functions, which are crucial in the fight against cancer.
Latest Patents
Joana Matos holds a patent for "Inhibitors of the activity of complex (III) of the mitochondrial electron transport chain and use thereof." This invention relates to inhibitors that can effectively reduce the activity of Complex (III) in the mitochondrial electron transport chain. The application of these inhibitors is aimed at the treatment and prevention of cancers that present tumor-initiating cells. Furthermore, her patent includes pharmaceutical compositions that incorporate these inhibitors, either alone or in combination with other active agents, for use as medicaments or agrochemicals.
Career Highlights
Joana Matos is associated with Stemergie Biotechnology SA, where she continues to advance her research and development efforts. Her work is characterized by a commitment to improving therapeutic options for cancer patients through innovative biotechnological solutions.
Collaborations
Joana collaborates with esteemed colleagues, including Virginie Clement-Schatlo and Thomas Fessard, who contribute to her research endeavors and help drive forward the mission of Stemergie Biotechnology SA.
Conclusion
Joana Matos exemplifies the spirit of innovation in biotechnology, with her groundbreaking patent addressing critical challenges in cancer treatment. Her work not only highlights her expertise but also underscores the importance of collaborative efforts in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile